Matucci-Cerinic, M., Allanore, Y., Kavanaugh, A., Buch, M. H., Schulze-Koops, H., Kucharz, E. J., . . . Schwebig, A. (2018). Efficacy, safety and immunogenicity of GP2015, an etanercept biosimilar, compared with the reference etanercept in patients with moderate-to-severe rheumatoid arthritis: 24-week results from the comparative phase III, randomised, double-blind EQUIRA study. RMD Open.

Matucci-Cerinic, Marco, et al. "Efficacy, Safety and Immunogenicity of GP2015, an Etanercept Biosimilar, Compared With the Reference Etanercept in Patients With Moderate-to-severe Rheumatoid Arthritis: 24-week Results From the Comparative Phase III, Randomised, Double-blind EQUIRA Study." RMD Open 2018.

Matucci-Cerinic, Marco, et al. "Efficacy, Safety and Immunogenicity of GP2015, an Etanercept Biosimilar, Compared With the Reference Etanercept in Patients With Moderate-to-severe Rheumatoid Arthritis: 24-week Results From the Comparative Phase III, Randomised, Double-blind EQUIRA Study." RMD Open 2018.